Banco Santander’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $254K | Sell |
1,606
-1,353
| -46% | -$183K | ﹤0.01% | 466 |
|
|
2026
Q1 | $378K | Buy |
2,959
+794
| +37% | +$99.1K | ﹤0.01% | 393 |
|
|
2025
Q4 | $264K | Sell |
2,165
-536
| -20% | -$61.5K | ﹤0.01% | 419 |
|
|
2025
Q3 | $271K | Sell |
2,701
-19,174
| -88% | -$1.73M | ﹤0.01% | 424 |
|
|
2025
Q2 | $1.81M | Buy |
21,875
+2,136
| +11% | +$170K | 0.02% | 277 |
|
|
2025
Q1 | $1.6M | Buy |
19,739
+5,218
| +36% | +$466K | 0.02% | 284 |
|
|
2024
Q4 | $1.31M | Buy |
14,521
+36
| +0.2% | +$3.49K | 0.02% | 258 |
|
|
2024
Q3 | $1.43M | Sell |
14,485
-534
| -4% | -$52.5K | 0.02% | 257 |
|
|
2024
Q2 | $1.39M | Sell |
15,019
-491
| -3% | -$44K | 0.02% | 247 |
|
|
2024
Q1 | $1.47M | Sell |
15,510
-1,230
| -7% | -$114K | 0.02% | 247 |
|
|
2023
Q4 | $1.49M | Buy |
16,740
+140
| +0.8% | +$10.4K | 0.02% | 254 |
|
|
2023
Q3 | $1.21M | Sell |
16,600
-558
| -3% | -$44.6K | 0.02% | 277 |
|
|
2023
Q2 | $1.43M | Sell |
17,158
-341
| -2% | -$28.5K | 0.02% | 253 |
|
|
2023
Q1 | $1.33M | Sell |
17,499
-1,367
| -7% | -$113K | 0.02% | 205 |
|
|
2022
Q4 | $1.57M | Sell |
18,866
-833
| -4% | -$67.4K | 0.02% | 198 |
|
|
2022
Q3 | $1.56M | Sell |
19,699
-325
| -2% | -$27.4K | 0.02% | 207 |
|
|
2022
Q2 | $1.49M | Sell |
20,024
-1,445
| -7% | -$108K | 0.02% | 240 |
|
|
2022
Q1 | $1.93M | Sell |
21,469
-4,050
| -16% | -$374K | 0.02% | 237 |
|
|
2021
Q4 | $2.86M | Sell |
25,519
-25,851
| -50% | -$3.12M | 0.02% | 216 |
|
|
2021
Q3 | $6.46M | Sell |
51,370
-91
| -0.2% | -$11.7K | 0.03% | 151 |
|
|
2021
Q2 | $6.97M | Buy |
51,461
+28,972
| +129% | +$3.81M | 0.04% | 139 |
|
|
2021
Q1 | $3.05M | Buy |
22,489
+549
| +3% | +$82.2K | 0.02% | 187 |
|
|
2020
Q4 | $3.09M | Sell |
21,940
-2,402
| -10% | -$308K | 0.02% | 180 |
|
|
2020
Q3 | $2.71M | Sell |
24,342
-8,481
| -26% | -$951K | 0.04% | 161 |
|
|
2020
Q2 | $3.67M | Sell |
32,823
-2,612
| -7% | -$257K | 0.05% | 122 |
|
|
2020
Q1 | $2.74M | Sell |
35,435
-6,672
| -16% | -$591K | 0.03% | 183 |
|
|
2019
Q4 | $4M | Sell |
42,107
-1,568
| -4% | -$136K | 0.04% | 150 |
|
|
2019
Q3 | $3.33M | Sell |
43,675
-829
| -2% | -$68.9K | 0.03% | 160 |
|
|
2019
Q2 | $3.9M | Sell |
44,504
-5,899
| -12% | -$503K | 0.04% | 156 |
|
|
2019
Q1 | $4.56M | Buy |
50,403
+5,574
| +12% | +$474K | 0.05% | 142 |
|
|
2018
Q4 | $3.22M | Buy |
44,829
+1,385
| +3% | +$112K | 0.04% | 171 |
|
|
2018
Q3 | $4.17M | Sell |
43,444
-2,328
| -5% | -$226K | 0.05% | 162 |
|
|
2018
Q2 | $4.36M | Sell |
45,772
-364
| -0.8% | -$33.5K | 0.05% | 159 |
|
|
2018
Q1 | $4.05M | Buy |
+46,136
| New | +$4.21M | 0.05% | 170 |
|
Other funds holding XBI
MIH
MSR
PR
SO
WT
Banco Santander's XBI Position: Q2 2026 in Review
Banco Santander reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 46% in Q2 2026, selling an estimated $183K and leaving 1,606 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #466.
Banco Santander first reported a position in XBI in Q1 2018 and has held it in 34 quarters since. The position peaked at $6.97M in Q2 2021. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Banco Santander held 1,606 shares of State Street SPDR S&P Biotech ETF worth $254K as of Q2 2026.
- Banco Santander sold 1,353 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $183K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Banco Santander's portfolio in Q2 2026, its #466 holding.
- Banco Santander first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 34 quarters since.
- Banco Santander's State Street SPDR S&P Biotech ETF position peaked at $6.97M in Q2 2021.
- 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.